Mechanisms of the resistance and tolerance to beta-lactam and glycopeptide antibiotics in pathogenic gram-positive cocci. 2009

A Mlynarczyk, and B Mlynarczyk, and M Kmera-Muszynska, and S Majewski, and G Mlynarczyk
Department of Medical Microbiology, Chalubinskiego 5, 02-004 Warsaw, Medical University of Warsaw, Poland.

Beta-lactams are the most frequently used antimicrobials in combating infections. In the case of gram-positive bacteria resistant to beta-lactams, glycopeptides are the first choice. The occurrence, mechanisms and genetic background of the resistance of pathogenic staphylococci, streptococci and enterococci to beta-lactam and glycopeptide antibiotics were discussed. The resistances to well-established antimicrobials, as well as new agents (ceftobiprole, oritavancin, telavancin, dalbavancin) were taken into consideration in the text.

UI MeSH Term Description Entries
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006020 Glycopeptides Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. Glycopeptide
D006095 Gram-Positive Cocci Coccus-shaped bacteria that retain the crystal violet stain when treated by Gram's method. Gram Positive Cocci
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D047090 beta-Lactams Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria. beta-Lactam,4-Thia-1-Azabicyclo(3.2.0)Heptanes,4-Thia-1-Azabicyclo(4.2.0)Octanes,beta Lactam,beta Lactams

Related Publications

A Mlynarczyk, and B Mlynarczyk, and M Kmera-Muszynska, and S Majewski, and G Mlynarczyk
December 1992, Infectious agents and disease,
A Mlynarczyk, and B Mlynarczyk, and M Kmera-Muszynska, and S Majewski, and G Mlynarczyk
January 2012, Interdisciplinary perspectives on infectious diseases,
A Mlynarczyk, and B Mlynarczyk, and M Kmera-Muszynska, and S Majewski, and G Mlynarczyk
May 1988, Hospital practice (Office ed.),
A Mlynarczyk, and B Mlynarczyk, and M Kmera-Muszynska, and S Majewski, and G Mlynarczyk
September 2007, Thrombosis and haemostasis,
A Mlynarczyk, and B Mlynarczyk, and M Kmera-Muszynska, and S Majewski, and G Mlynarczyk
January 2001, International journal of antimicrobial agents,
A Mlynarczyk, and B Mlynarczyk, and M Kmera-Muszynska, and S Majewski, and G Mlynarczyk
September 1985, The Journal of antimicrobial chemotherapy,
A Mlynarczyk, and B Mlynarczyk, and M Kmera-Muszynska, and S Majewski, and G Mlynarczyk
May 1979, The Journal of infectious diseases,
A Mlynarczyk, and B Mlynarczyk, and M Kmera-Muszynska, and S Majewski, and G Mlynarczyk
February 1985, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
A Mlynarczyk, and B Mlynarczyk, and M Kmera-Muszynska, and S Majewski, and G Mlynarczyk
January 1993, Infection,
A Mlynarczyk, and B Mlynarczyk, and M Kmera-Muszynska, and S Majewski, and G Mlynarczyk
January 1991, Scandinavian journal of infectious diseases. Supplementum,
Copied contents to your clipboard!